Friday, January 26, 2024 2:32:56 PM
Kiwi
Recent ALPN News
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 05/07/2024 12:30:29 PM
- Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm • PR Newswire (US) • 04/11/2024 08:27:00 PM
- Costco Increases Dividend by 14%, Meta Introduces ‘Artemis’ AI Chip, and More News • IH Market News • 04/11/2024 11:24:54 AM
- Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy • Business Wire • 04/10/2024 08:15:00 PM
- Vertex Enters Into Agreement to Acquire Alpine Immune Sciences • Business Wire • 04/10/2024 08:01:00 PM
- Vertex Enters Into Agreement to Acquire Alpine Immune Sciences • Business Wire • 04/10/2024 08:01:00 PM
- Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024 • Business Wire • 04/01/2024 01:00:00 PM
- Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024 • Business Wire • 03/21/2024 11:45:00 AM
- Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference • Business Wire • 03/20/2024 08:30:00 PM
- Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results • Business Wire • 03/18/2024 08:05:00 PM
- Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 03/07/2024 09:30:00 PM
- Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences • Business Wire • 02/26/2024 09:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:43:28 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:22:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:12:02 PM
- Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences • Business Wire • 02/01/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 11:54:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 11:08:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 11:06:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:45:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 12:06:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 12:05:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:23:56 PM
- Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie • Business Wire • 12/21/2023 09:15:00 PM
- Alpine Immune Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 12/18/2023 09:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM